Compound probiotic freeze-dried powder

Abstract

The invention belongs to the technical field of probiotic products, and particularly relates to compound probiotic freeze-dried powder. The bifidobacterium infantis freeze-dried powder comprises the following components in percentage by mass: 45-60% of compound saccharides, 4-6% of bifidobacterium infantis freeze-dried powder, 3-4% of bifidobacterium lactis freeze-dried powder, 2-4% of bifidobacterium adolescentis freeze-dried powder, 3-5% of lactobacillus rhamnosus freeze-dried powder, 2-4% of lactobacillus casei freeze-dried powder, 3-5% of bifidobacterium longum freeze-dried powder, 2-4% oflactobacillus reuteri freeze-dried powder, 1-3% of bifidobacterium animalis and 15-20% of a milk product additive. According to the composite probiotic freeze-dried powder disclosed by the invention,on the basis of adopting a traditional production and preparation method, multiple strains are scientifically combined for use, so that the effects of improving the adjuvant therapy effect of probiotics on hyperbilirubinemia, shortening the hyperbilirubinemia treatment period, improving the physique of infants and young children and the like are achieved, the cure rate is further increased, and the medical time and the medical cost are reduced.

Description

technical field [0001] The application belongs to the technical field of probiotic products, in particular to a composite probiotic freeze-dried powder. Background technique [0002] Hyperbilirubinemia (NHB) is a disease with a very high incidence in infants and young children. Generally speaking, mild patients can be effectively treated by reasonable phototherapy and prudent drug treatment. However, in the actual diagnosis and treatment process, for many areas with underdeveloped economy and medical technology, this kind of therapy has not been effectively used, because the yellow stains and poor appetite of the disease are not very intuitive to ordinary people. And it is eye-catching, so it is ignored by many parents, especially parents and elders with old age and concepts. In fact, hyperbilirubinemia will not only lead to poor mental state of infants and young children in the short term, if not treated in time, In severe cases, it may cause bilirubin-induced damage to mu...

AI Technical Summary

Problems solved by technology

However, in the actual diagnosis and treatment process, for many areas with underdeveloped economy and medical technology, this kind of therapy has not been effectively used, because the yellow stains and poor appetite of the disease are not very intuitive to ordinary people. And it is eye-catching, so it is ignored by many parents, especially parents and elders with old ideas and old ideas. In fact, hyperbilirubinemia will not only lead to poor mental state of infants and young children in the short term, if not treated in time, In severe cases, it may cause bilirubin-induced damage to multiple organs, reduce the immunity of infants and young children, and even cause serious damage to the central nervous system

Restricted by the environment and economic conditions, many parents insist on arranging sun exposure by themselves. In the family environment, due to the inability to obtain scientific treatment plans and abilities, the actual recovery effect and speed cannot be expected. However, with probiotics With the continuous emergence of bacterial products, people began to pay attention to and study the therapeutic effect of oral probiotics on hyperbilirubinemia, and published many research results. The research objects mainly focus on the probiotics that have been approved and used in China. However, the main purpose of this kind of probiotics is to assist the intestinal regulation of infants and young children and improve their immunity. Objectively speaking, the above functions actually have an indirect effect on improving hyperbilirubinemia. Whether it is really directly effective Probiotic products that improve the efficiency of treatment and recovery in this condition are debatable

Images